Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
Inetetamab in Combination With Pyrotinib in HER2 Mutant or Amplified Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT05016544. IPD Sharing: NO. Countries: 1. Publications: 15.
A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma
ClinicalTrials.gov study NCT02491099. IPD Sharing: Not stated. Countries: 1. Publications: 6.
A Phase I, Multicenter, Open-Label, Multi-Part, Dose-escalation Study of RAD1901 in Postmenopausal Women With Advanced Estrogen Receptor Positive and HER2-Negative Breast Cancer
ClinicalTrials.gov study NCT02338349. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pyrotinib Plus Trastuzumab and Chemotherapy in HER2+ Metastatic Breast Cancer Patients
ClinicalTrials.gov study NCT05839288. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trastuzumab, Bevacizumab with Paclitaxel for HER2-positive Gastric Cancer in a Second-line Therapy
ClinicalTrials.gov study NCT05640830. IPD Sharing: NO. Countries: 1. Publications: 11.
Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer
ClinicalTrials.gov study NCT03571633. IPD Sharing: Not stated. Countries: 1. Publications: 20.
Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer
ClinicalTrials.gov study NCT01822314. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC
ClinicalTrials.gov study NCT04262804. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-HE3-G3
ClinicalTrials.gov study NCT04277338. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Famitinib Malate in HER2-negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT01653574. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Data from: Effect of methylcobalamin on capecitabine-induced hand-foot syndrome in patients with HER2-negative early breast cancer: A multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Open the record for dataset details and reuse information.
Towards establishing extracellular vesicle-associated RNAs as biomarkers for HER2+ breast cancer
Open the record for dataset details and reuse information.
Supplementary data for "Profiling the peripheral immune landscape of metastatic HER2+ breast cancer"
<p>Supplementary data (Supplementary Table III.1) and high-resolution versions of figures III.3 - III.9 for Chapter III of the PhD thesis "The effect of dual HER2 blockade on anti-tumor immune cells" (ITQB-NOVA, Oeiras, Portugal).</p>
Dataset for the manuscript: Serum HER2 as potential prognostic biomarker in primary breast cancer patients
Open the record for dataset details and reuse information.
RNA-seq gene expression profiles from female ER-positive HER2-normal breast cancer patients
<p>Diagnostic samples (<em>n</em> = 59) from female breast cancer patients with ER-positive and HER2-normal tumors selected for neoadjuvant chemotehrapy.<br> </p> <p><strong>Data contents</strong></p> <table> <tbody> <tr> <td>README.txt</td> <td>README file</td> </tr> <tr> <td>meta_mat.tsv</td> <td>Metadata table</td> </tr> <tr> <td>expr_mat_probes.tsv.gz</td> <td>Expression matrix with probeset identifiers</td> </tr> <tr> <td>expr_mat_genes.tsv.gz</td> <td>Expression count matrix with gene identifiers</td> </tr> </tbody> </table>
MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer
ClinicalTrials.gov study NCT02536794. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pyrotinib Plus Vinorelbine in HER2+ Metastatic Breast Cancer Patients
ClinicalTrials.gov study NCT04517305. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study of Poziotinib in Participants With HER2-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT02659514. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
ClinicalTrials.gov study NCT01026142. IPD Sharing: Not stated. Countries: 23. Publications: 0.
A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients
ClinicalTrials.gov study NCT01905592. IPD Sharing: NO. Countries: 14. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.